Renaissance Technologies
CALC icon

Renaissance Technologies’s CalciMedica CALC Stock Holding History

Renaissance Technologies’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$77.7K Buy
47,980
+28,520
+147% +$87.8K ﹤0.01% 3038
2026
Q2 		$100K Sell
19,460
-6,155
-24% -$21.8K ﹤0.01% 2977
2026
Q1 		$69.2K Buy
25,615
+7,955
+45% +$80.7K ﹤0.01% 3075
2025
Q4 		$582K Buy
17,660
+3,660
+26% +$71.4K ﹤0.01% 2512
2025
Q3 		$215K Buy
14,000
+6,800
+94% +$97.8K ﹤0.01% 3112
2025
Q2 		$57.6K Buy
7,200
+117
+2% +$1K ﹤0.01% 3374
2025
Q1 		$67.6K Sell
7,083
-1,557
-18% -$19.4K ﹤0.01% 3249
2024
Q4 		$153K Buy
+8,640
New +$151K ﹤0.01% 3224
2023
Q1 		– Sell
-2,229
Closed -$78K – 3998
2022
Q4 		$78K Sell
2,229
-635
-22% -$35.6K ﹤0.01% 3692
2022
Q3 		$189K Buy
2,864
+2,120
+285% +$150K ﹤0.01% 3402
2022
Q2 		$57K Buy
744
+239
+47% +$16.3K ﹤0.01% 3976
2022
Q1 		$43K Buy
505
+348
+222% +$33.1K ﹤0.01% 3928
2021
Q4 		$20K Buy
+157
New +$30.5K ﹤0.01% 3838

Other funds holding CALC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Renaissance Technologies's CALC Position: Q3 2026 in Review

Renaissance Technologies increased its CalciMedica (CALC) stake by 147% in Q3 2026, buying an estimated $87.8K and bringing the position to 47,980 shares worth $77.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3038.

Renaissance Technologies first reported a position in CALC in Q4 2021 and has held it in 13 quarters since. The position peaked at $582K in Q4 2025. 8 funds tracked by Wall St. Rank hold CALC as of Q3 2026.

  • Renaissance Technologies held 47,980 shares of CalciMedica worth $77.7K as of Q3 2026.
  • Renaissance Technologies bought 28,520 CalciMedica shares in Q3 2026, an estimated $87.8K.
  • CalciMedica made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #3038 holding.
  • Renaissance Technologies first reported a position in CalciMedica in Q4 2021 and has held it in 13 quarters since.
  • Renaissance Technologies's CalciMedica position peaked at $582K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held CalciMedica as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.